| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/16/1999 | WO1999045927A1 Vitronectin receptor antagonists |
| 09/16/1999 | WO1999045913A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999045779A1 Novel compositions of eprosartan |
| 09/16/1999 | WO1999045775A1 Compositions and methods for modulating vascularization |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | WO1999028304A9 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/16/1999 | WO1998056759A3 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/16/1999 | CA2323496A1 Enzyme inhibitors |
| 09/16/1999 | CA2323456A1 Benzofurylpyrone derivatives |
| 09/16/1999 | CA2323208A1 Vitronectin receptor antagonists |
| 09/16/1999 | CA2322873A1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/16/1999 | CA2322839A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2322824A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941994A1 Pyrazolopyrimidines and pyrazolotriazines with 5-HT6 receptor affinity |
| 09/15/1999 | EP0941355A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941342A1 Human squalene epoxidase |
| 09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941245A1 Promoter for smooth muscle cell expression |
| 09/15/1999 | EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 09/15/1999 | EP0941218A1 Antithrombotic organic nitrates |
| 09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
| 09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
| 09/15/1999 | EP0941116A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 09/15/1999 | EP0941096A2 A method for lowering plasma levels of lipoprotein(a) |
| 09/15/1999 | EP0941090A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
| 09/15/1999 | EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases |
| 09/15/1999 | EP0941081A2 New use of creatine |
| 09/15/1999 | EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 09/15/1999 | EP0799188B1 Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor |
| 09/15/1999 | EP0759899B1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0733051B1 Bicyclic heterocycles as neurokinin a antagonists |
| 09/15/1999 | EP0656001B1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 09/15/1999 | CN1228780A Phosphinic acid amides as matrix metalloprotease inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228770A Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 09/15/1999 | CN1228767A Bidentate metalloprotease inhibitors |
| 09/15/1999 | CN1228698A Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine derivative and HMG-CoA-reductase inhibitor |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228319A Chinese patent drug for curing hypertension |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952381 Para-substituted phenylene derivatives |
| 09/14/1999 | US5952364 Methods for inhibiting smooth muscle cell proliferation |
| 09/14/1999 | US5952354 Enzyme inhibitors of chloesterol ester hydrolase and/or acyl coenzyme a:chloesterol acyltransferase; inhibit the esterification of chloesterol and reduce absorption through the intestine; carbamates of 4-8 membered azacycloalkanols |
| 09/14/1999 | US5952342 1,6-naphthyridines effective in treating atherosclerosis, restenosis and psoriasis; anticarcinogenic and -proliferative agents; bactericides |
| 09/14/1999 | US5952337 Remedy and preventive for nervous system disorders |
| 09/14/1999 | US5952327 Neutral endopeptidase inhibitors; treatment of cardiovascular disorders |
| 09/14/1999 | US5952322 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| 09/14/1999 | US5952305 Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims |
| 09/14/1999 | US5952296 Method of using relaxin as therapeutic or preventing agent |
| 09/14/1999 | CA2153264C New cyclopropyl derivatives, preparation method thereof and applications |
| 09/14/1999 | CA2006356C Arylpiperazinylbutyl-dihydroindoles and related compounds |
| 09/10/1999 | WO1999045127A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045126A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045016A2 Novel prodrugs for phosphorus-containing compounds |
| 09/10/1999 | WO1999045011A1 Glycine transport inhibitors |
| 09/10/1999 | WO1999045009A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 09/10/1999 | WO1999044998A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
| 09/10/1999 | WO1999044994A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999044612A1 Substituted quinazolines and analogs and the use thereof |
| 09/10/1999 | WO1999033840A3 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action |
| 09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
| 09/10/1999 | WO1999023078A3 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 09/10/1999 | WO1999021617B1 Allosteric adenosine receptor modulators |
| 09/10/1999 | WO1999020756A3 Human toll homologues |
| 09/10/1999 | CA2322664A1 Enhanced prodrug activation |
| 09/10/1999 | CA2322541A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
| 09/10/1999 | CA2322207A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists |
| 09/10/1999 | CA2322136A1 Glycine transport inhibitors |
| 09/10/1999 | CA2249661A1 Novel compounds |
| 09/10/1999 | CA2249041A1 Novel compounds |
| 09/09/1999 | DE19809144A1 Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten New asymmetrically substituted carboxylic acid derivatives, their preparation and use as a mixed ET¶LAMBDA¶ / ET¶B¶ receptor antagonists |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939770A1 Receptor specific brain natriuretic peptide (bnp) |
| 09/08/1999 | EP0939758A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/08/1999 | EP0939654A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
| 09/08/1999 | EP0791004B1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 09/08/1999 | EP0722460B1 Derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 09/08/1999 | CN1228087A Substituted pyrimidine derivatives and their pharmaceutical use |
| 09/08/1999 | CN1228018A Liposomal compositions and method of using them |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948811 Psychological disorders; parkinson's disease |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948799 Method for improving morbidity and/or mortality |